Immunovant Overview
Immunovant Target Price
Analysts' 12-month price predictions for IMVT.
Share Price
$16.95
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-09-10 | H.C. WainwrightDouglas Tsao | $51 |  200.9% upside |  |
| 2024-06-03 | OppenheimerLeland Gershell | $46 | 171.4% upside | |
| 2024-05-30 | GuggenheimYatin Suneja | $48 | 183.2% upside | |
| 2024-05-30 | Piper SandlerYasmeen Rahimi | $57 | 236.3% upside | |
| 2024-03-13 | Goldman SachsCorinne Johnson | $50 | 195% upside | |
| 2022-09-26 | UBSColin Bristow | $5 |  70.5% downside | |